Antiganglioside, antibody profiles in 249 cases of Guillain-Barré syndrom;Les profils autoanticorps antigangliosides dans le syndrome de Guillain-Barré

Annales de Biologie Clinique

Volumn 60, Issue 5, 2002, Pages 589-597

  Caudie, C ^a   Vial, C ^a   Bancel, J ^a   Petiot, P ^a   Antoine, J C ^a   Gonnaud, P M ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Anti ganglioside antibody; Anti GD1b antibody; Anti GM1 antibody; Anti GM2 antibody; Anti GQ1b antibody; Anti GT1b antibody; Guillain Barr syndrome; Miller Fisher syndrome

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; AUTOANTIBODY; DRUG DERIVATIVE; GANGLIOSIDE; GANGLIOSIDE GD1ALPHA; GANGLIOSIDE, GD1B; GANGLIOSIDE, GT1; GQ1B GANGLIOSIDE;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CAMPYLOBACTER JEJUNI; CHILD; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYRADICULONEUROPATHY; THIN LAYER CHROMATOGRAPHY; BLOOD; CHEMISTRY; CLASSIFICATION; HOSPITALIZATION; IMMUNOBLOTTING; IMMUNOLOGY; INFANT; METHODOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, THIN LAYER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M1) GANGLIOSIDE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036726009     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27 (Suppl.): S21-S24.
2. Van der Meché FGA, Van Doorn PA. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mecanisms and update on current therapies. Ann Neurol 1995; 37: S14-S31.
3. Van der Meché FG, Van Doorn PA, Meulstee J, Jennekens FG. GBS-consensus group of the dutch neuromuscular research support centre. Eur Neurol 2001; 45: 133-9.
4. Jacobs BC, Rothbarth PH, van der Meché FGA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome. A case-control study. Neurology 1998; 51: 1110-5.
5. Hartung HP, Kieseier RC. Antibody responses in the Guillain-Barré syndrome. J Neurol Sci 1999; 168: 75-7.
6. Carpo M, Pedotti R, Allaria S, et al. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 1999; 168: 78-84.
7. Chabraoui F, Derrington EA, Mallié-Didier F, Confavreux C, Quincy CI, Caudie C. Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membrane. J Immunol Methods 1993; 165: 225-30.
8. Caudie C, Vial C, Petiot P, Bancel J, Later R, Gonnaud PM. Détection des autoanficorps antigangliosides par immunodot-blot: intérêt dans le diagnostic des neuropathies périphériques auto-immunitaires. Ann Biol Clin 1999; 57: 579-88.
9. Caudie C, Vial C, Petiot P, Bancel J, Lombard C, Gonnaud PM. Activité autoanticorps des IgM monoclonales vis-à-vis des glycoconjugués du nerf périphérique: propos de 112 cas. Ann Biol Clin 2001; 59: 567-77.
10. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990; 40: 1900-2.
11. McKhann GM, Comblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333-42.
12. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986; 109: 1115-26.
13. Feasby TE, Hahn AF, Brown WF, et al. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mecanisms? J Neurol Sci 1993; 116: 185-92.
14. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995; 118: 597-605.
15. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med 1993; 178: 1771-5.
16. Yuki N, Takahashi M, Tagawa Y, et al. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome. Ann Neurol 1997; 42: 28-33.
17. Chowdhury D, Arora A. Axonal Guillain-Barré syndrome: a critical review. Acta Neurol Scand 2001; 5: 267-77.
18. Yuki N, Yoshino H, Sato S, Shinozawa K, Miyatake T. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 1992; 15: 899-903.
19. Yuki N, Yamada M, Sato S, et al. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome. Muscle Nerve 1993; 16: 642-7.
20. Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibodies is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999; 45: 168-73.
21. Yuki N, Taki T, Takahashi M, et al. Penner's serotype 4 of Campylobacter jejuni has a polysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect Immun 1994; 62: 2101-3.
22. Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marquer of Miller Fisher syndrome. Ann Neurol 1992; 31: 677-9.
23. Willison HJ, Veich J, Paterson G, Kennedy PGE, Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993; 56: 204-6.
24. Yuki N, Sato S, Tsuji S, Ohsawa T, Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 1993; 43: 414-7.
25. Durand MC, Goulon-Goéau C. Schweitzer A, Chéliout-Héraut F, Raphael JC, Gajdos P. Étude électrophysiologique de 10 cas de syndrome de Miller Fisher. Rev Neurol 2001; 157: 1: 72-9.
26. Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQ1b ganglioside and lipopolycaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 1994; 36: 791-3.
27. Ter Bruggen JP, Van der Meché FGA, De Jager AEJ, Polman CH. Ophthamoplegic and lower cranial nerve variants merge into classical Guillain-Barré syndrome. Muscle Nerve 1997; 21: 239-42.
28. Willison HJ, Almemar A, Veich J, Thrush D. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology 1994; 44: 2395-7.
29. Miyazaki T, Kusunoki S, Kaida K, Shiina M, Kanazawa I. GuillainBarré syndrome associated with IgG monospecific to ganglioside GD1b. Neurology 2001; 56: 1227-9.
30. Irie S, Saito T, Nakamura K, et al. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection. J Neuroimmunol 1996; 68: 19-26.
31. Visser LH, Van Der Meché FGA, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic and pronostic features. Neurology 1996; 47: 668-73.
32. Quarles RH, Weiss MD. Autoantibodies associated with peripheral neuropathy. Muscle Nerve 1999; 22: 800-22.